135 related articles for article (PubMed ID: 11986184)
1. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience.
Henry-Tillman RS; Korourian S; Rubio IT; Johnson AT; Mancino AT; Massol N; Smith LF; Westbrook KC; Klimberg VS
Ann Surg Oncol; 2002 May; 9(4):333-9. PubMed ID: 11986184
[TBL] [Abstract][Full Text] [Related]
2. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
7. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
8. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
Dabbs DJ; Fung M; Johnson R
Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
[TBL] [Abstract][Full Text] [Related]
10. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer.
van de Vrande S; Meijer J; Rijnders A; Klinkenbijl JH
Eur J Surg Oncol; 2009 Mar; 35(3):276-80. PubMed ID: 18786801
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intraoperative scrape cytology for sentinel lymph node biopsy in patients with breast cancer.
Teal CB; Tabbara S; Kelly TA
Breast J; 2007; 13(2):155-7. PubMed ID: 17319856
[TBL] [Abstract][Full Text] [Related]
12. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.
Martin RC; Edwards MJ; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; McMasters KM
Surgery; 2000 Aug; 128(2):139-44. PubMed ID: 10922983
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer.
Wada N; Imoto S; Hasebe T; Ochiai A; Ebihara S; Moriyama N
Jpn J Clin Oncol; 2004 Mar; 34(3):113-7. PubMed ID: 15078905
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
15. Comparing touch imprint cytology, frozen section analysis, and cytokeratin immunostaining for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.
Safai A; Razeghi A; Monabati A; Azarpira N; Talei A
Indian J Pathol Microbiol; 2012; 55(2):183-6. PubMed ID: 22771640
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
[TBL] [Abstract][Full Text] [Related]
18. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.
Layeeque R; Kepple J; Henry-Tillman RS; Adkins L; Kass R; Colvert M; Gibson R; Mancino A; Korourian S; Klimberg VS
Ann Surg; 2004 Jun; 239(6):841-5; discussion 845-8. PubMed ID: 15166963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
